Journal update monthly top five
The St. Vincent's Emergency Research Group has curated a set of five highly relevant papers from outside the core field of emergency medicine for consensus review this month. Of these, one paper stands out significantly as a potential practice modifier: the TRACE-5 trial comparing tenecteplase to standard care specifically for basilar artery occlusion within 24 hours. Basilar artery occlusion represents a severe posterior circulation stroke with high associated morbidity and mortality rates. The authors have assessed this evidence, rating it as a 'game changer,' which strongly suggests that current guidelines or local protocols may need revision regarding reperfusion strategies in these complex acute ischemic events.
The St. Vincent's Emergency Research Group has curated a set of five highly relevant papers from outside the core field of emergency medicine for consensus review this month. Of these, one paper stands out significantly as a potential practice modifier: the TRACE-5 trial comparing tenecteplase to standard care specifically for basilar artery occlusion within 24 hours. Basilar artery occlusion represents a severe posterior circulation stroke with high associated morbidity and mortality rates. The authors have assessed this evidence, rating it as a 'game changer,' which strongly suggests that current guidelines or local protocols may need revision regarding reperfusion strategies in these complex acute ischemic events.
Show moreShow less
Given the 'game changer' designation for TRACE-5, you should pay close attention to how tenecteplase is positioned versus standard care for basilar artery occlusion within 24 hours. While this suggests a potential shift in posterior circulation stroke management, remember that consensus reviews are always evolving; therefore, confirm local institutional protocols against these new findings before making any definitive changes at the bedside.